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Abstract
This study provides EQ-5D population norms for 20 countries (N = 163,838), which can be used to compare profiles for 
patients with specific conditions with data for the average person in the general population in a similar age and/or gender 
group. Descriptive EQ-5D data are provided for the total population, by gender and by seven age groups. Provided index 
values are based on European VAS for all countries, based on TTO for 11 countries and based on VAS for 10 countries. 
Important differences exist in EQ-5D reported health status across countries after standardizing for population structure. 
Self-reported health according to all five dimensions and EQ VAS generally decreased with increasing age and was lower 
for females. Mean self-rated EQ VAS scores varied from 70.4 to 83.3 in the total population by country. The prior living 
standards (GDP per capita) in the countries studied are correlated most with the EQ VAS scores (0.58), while unemployment 
appeared to be significantly correlated in people over the age of 45 only. A country’s expenditure on health care correlated 
moderately with higher ratings on the EQ VAS (0.55). EQ-5D norms can be used as reference data to assess the burden of 
disease of patients with specific conditions. Such information, in turn, can inform policy-making and assist in setting priori-
ties in health care.
Keywords Health state values · EQ-5D · Population norms · Health-related quality of life
JEL Classification I10 · I30 · J11 · H51
Introduction
EQ-5D is a standardized health-related quality of life ques-
tionnaire developed by the EuroQol Group in order to pro-
vide a simple, generic measure of health for clinical and 
economic appraisal [1]. Applicable to a wide range of health 
conditions, it provides a simple descriptive profile, a self-
report visual analogue scale (EQ VAS) and an index value 
(‘utility’) for health status that can be used in the clinical and 
economic evaluation of health care as well as in population 
health surveys.
Since EQ-5D was first developed, a substantial amount 
of research has been carried out worldwide using the instru-
ment [2]. Among this research were surveys conducted in 
various countries that measured the health-related quality 
of life of the general population [3]. These EQ-5D surveys 
have been informative in providing new data on population 
health characteristics, complementing the traditionally col-
lected morbidity and mortality data.
Although recently an expanded five-level version of the 
EQ-5D instrument (EQ-5D-5L) has become available and 
was translated for use across countries, the general popula-
tion survey datasets available in the EuroQol archive that 
were analyzed in this study were still based on the original 
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three-level version of the EQ-5D (EQ-5D-3L), here referred 
to as EQ-5D.
The purpose of the current study is to present EQ-5D 
population norms for 20 countries, including reported prob-
lems by the five EQ-5D dimensions, self-reported EQ VAS 
ratings (by country, age, and gender), and EQ-5D index 
values (by country, age, and gender). The index values, 
presented in country-specific value sets, are a major feature 
of the EQ-5D instrument. EQ-5D value sets are typically 
obtained using representative samples of the general public, 
thereby ensuring that they represent the societal perspective, 
traditionally based on visual analogue scale (VAS) and time 
trade-off (TTO) valuation techniques. Apart from VAS- and 
TTO-based value sets, we also included the European VAS-
based value set as a common metric for all countries. We 
hypothesized that reported health problems will increase by 
age and will be higher for females. Cross-country analyses 
of population health based on EQ-5D are presented with the 
aim of exploring which macroeconomic factors are associ-
ated with the self-reported health of the population. Addi-
tionally, we performed exploratory analyses on comparing 
the different value sets.
Methods
Data
Datasets per country were generally made available through 
the central data archive of the EuroQol Research Foundation. 
Countries included in the analysis were: Argentina, Bel-
gium, China, Denmark, England, Finland, France, Germany, 
Greece, Hungary, Italy, Korea, the Netherlands, New Zea-
land, Slovenia, Spain, Sweden, Thailand, United Kingdom, 
and the United States [4–18]. For two countries (Argentina 
and China), the dataset transfer to the central archive was 
not possible. For these countries, data were analyzed locally 
by two collaborating researchers (FA, SS, respectively). All 
of the surveys included the standardized three-level version 
of EQ-5D, using the appropriate language version in each 
country. The Dutch, Swedish, and Finnish versions were 
translated in 1987 according to a ‘simultaneous’ process 
while the remaining versions were translated according to 
the EuroQol Group’s translation protocol based on interna-
tional guidelines.
Table 1 provides a detailed account of the data by coun-
try. All datasets were collected in representative samples of 
the general population for each country. The datasets were 
structured in a standardized format to facilitate comparative 
research, although each survey also has its own character-
istics and variables specific to the individual research con-
text in which they were conducted. The datasets captured 
for the current analyses include observations on 163,838 
individuals. Sampling weights were applied for Belgium, 
England, France, Germany, Italy, the Netherlands, and Spain 
according to a stratified, multistage, cluster-area, probability-
sample design [5]. For the United States, sampling weights 
were applied resulting from a sampling design including 
stratification, clustering, multiple stages of selection, and 
oversampling of minority populations [18].
Surveys differed in methods of data collection and sample 
sizes. Some of the surveys were postal, while others were 
performed as part of a face-to-face interview or administered 
by telephone. The Argentinean dataset had the largest sam-
ple with over 41,000 respondents, while the Greek and the 
Swedish national surveys had the smallest sample of around 
500 respondents.
Methods of describing population norms
Population norm data were calculated for the five dimen-
sions, self-rated EQ VAS, and EQ-5D index values for the 
total population, by gender, and the following age groups: 
18–24, 25–34, 35–44, 45–54, 55–64, 65–74, and 75 + years. 
Aggregate EQ-5D dimension results were dichotomized, 
reporting the proportion of respondents scoring any problem 
on each dimension (the sum of the proportion of reported 
level-2 and level-3 problems). EQ-5D index value were cal-
culated using the following value sets: European VAS value 
set for all countries, country-specific time trade-off (TTO) 
value set if available (11 countries), and country-specific 
VAS value set if available (10 countries).
The TTO method has played an important role in gen-
erating value sets for the EQ-5D as one of the most widely 
accepted preference elicitation methods in economic evalu-
ation [19] and the method of choice in the first [20] and 
several subsequent large-scale EQ-5D valuation studies 
[21]. The VAS has become the other widely used valua-
tion method to elicit preferences for the EQ-5D, including 
9 countries. Note that the VAS valuation method needs to 
be distinguished from the EQ VAS, which is a self-reported 
rating of the respondents’ own health. The European VAS 
value set was constructed using data from 11 valuation stud-
ies in 6 countries: Finland (1), Germany (3), The Nether-
lands (1), Spain (3), Sweden (1), and the UK (2). This survey 
included sufficient data from different European regions to 
make the European VAS dataset moderately representative 
for Europe [22, 23]. Relevant information on the TTO- and 
VAS-based value sets, including the scoring algorithms, can 
be found in Szende et al. [21], Xie et al. [24], and Scalone 
et al. [25].
Results were tabulated in alphabetic order.
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Table 1  National representative EQ-5D population surveys
Country Source Sample size Data collection Survey method
Argentina Second National Survey of Risk Factors, 
2005 [4]
41,392 2005 Face-to-face interviews on the representa-
tive 2005 Risk Factors Survey on a random 
selection of households
Belgium ESEMED, König et al. [5] 2411 2001–2003 Computer-assisted home interviews on a 
nationally representative sample of the non-
institutionalized general adult population as 
part of the European Study of the Epidemiol-
ogy of Mental Disorders (ESEMeD), using a 
stratified probability sample design
China Sun et al. [6] 8031 2010 Face-to-face interviews on the representative 
2010 Household Health Survey (HHS), using 
a stratified, multi-stage, clustered, random 
sampling design
Denmark Sørensen et al. [7] 16,861 2000–2001 Face-to-face interviews on three representative 
national surveys based on randomized sam-
ples, including a national health interview 
survey undertaken by the National Institute of 
Public Health (SUSY-2000), a health survey 
undertaken in Funen County (Funen data set) 
and a national health survey undertaken by 
the University of Southern Denmark (SDU 
data set) with a total of 22,486 individuals
England Health Survey for England 2008 [8] 14,763 2008 Computer-assisted interviews on a randomly 
selected sample of households in England
Finland Saarni et al. [9] 8028 2000 Face-to-face interviews on the Health 2000 sur-
vey sample, which is a representative survey 
of the Finnish population aged 30 and over, 
following a two-stage, stratified, clustered 
sampling design
France ESEMED, König et al. [5] 2892 2001–2003 Computer-assisted home interviews on a 
nationally representative sample of the non-
institutionalized general adult population as 
part of the European Study of the Epidemiol-
ogy of Mental Disorders (ESEMeD), using a 
stratified probability sample design
Germany ESEMED, König et al. [5] 3552 2001–2003 Computer-assisted home interviews on a 
nationally representative sample of the non-
institutionalized general adult population as 
part of the European Study of the Epidemiol-
ogy of Mental Disorders (ESEMeD), using a 
stratified probability sample design
Greece Yfantopoulous [10] 464 1998 Face-to-face interviews on a sample of 500 
individuals selected from the general 
population, using quota sampling to ensure 
representativeness
Hungary Szende and Nemeth [11] 5503 2000 Self-administered questionnaire during a per-
sonal interview on a random sample of 7000 
people from the electoral registry
Italy ESEMED, König et al. [5] 4709 2001–2003 Computer-assisted home interviews on a 
nationally representative sample of the non-
institutionalized general adult population as 
part of the European Study of the Epidemiol-
ogy of Mental Disorders (ESEMeD), using a 
stratified probability sample design
Korea Lee et al. [12] 1307 2007 Face-to-face interviews on a random sample of 
the South Korean residential registry
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Cross‑country analysis
It is important to note that while results in each age group 
may be compared across countries, the total population 
scores cannot be compared directly, as they reflect the unique 
age structure within each country. Cross-country summary 
data for reported problems by the five dimensions and EQ 
VAS were estimated using a standardized population struc-
ture for all countries with national EQ-5D surveys. Stand-
ardization for age was performed to avoid bias due to the fact 
that some populations have a relatively higher proportion of 
elderly people. Age standardization of reported problems by 
dimension and EQ VAS were based on the European popu-
lation structure using Eurostat data from 2010 [26], using 
the following proportions for each age group: 11% (18–24), 
17% (25–34), 18% (35–44), 18% (45–54), 15% (55–64), 11% 
(65–74), and 10% (75 +).
To explore reasons for cross-country differences in 
EQ-5D data, correlations between country-specific EQ-5D 
data (five dimensions and self-rated EQ VAS) and country-
specific macroeconomic indicators were calculated, includ-
ing indicators of living standards and health system perfor-
mance. Living standards were estimated by means of gross 
domestic product (GDP) per capita and unemployment rate. 
Indicators for health care system performance were health 
expenditure per capita and health expenditure as a percent-
age of GDP, number of hospital beds per 1000 people, and 
number of physicians per 1000 people. The indicators were 
selected on the basis of a presumed or possible relation-
ship with self-reported health. Data were obtained from the 
World Health Organization Statistical Information System 
and the World Bank [27, 28]. The data were from 2010 or 
the closest year with available data (Table 2). An alternative 
set of macro data was also used to see how results might 
change when using macro data from the same year as the 
EQ-5D data collection, including variables on gross national 
income on purchasing power parity, unemployment rate, and 
health expenditure data.
Table 1  (continued)
Country Source Sample size Data collection Survey method
Netherlands ESEMED, König et al. [5] 2367 2001–2003 Computer-assisted home interviews on a 
nationally representative sample of the non-
institutionalized general adult population as 
part of the European Study of the Epidemiol-
ogy of Mental Disorders (ESEMeD), using a 
stratified probability sample design
New Zealand Devlin et al. [13] 1327 1999 Postal survey on a randomized sample of 3000 
New Zealanders selected from the electoral 
roll
Slovenia Prevolnik Rupel and Rebolj [14] 742 2000 Postal survey on a randomized sample of 3000 
people selected from the general population
Spain ESEMED, König et al. [5] 5473 2001–2003 Computer-assisted home interviews on a 
nationally representative sample of the non-
institutionalized general adult population as 
part of the European Study of the Epidemiol-
ogy of Mental Disorders (ESEMeD), using a 
stratified probability sample design
Sweden Bjork et al. [15] 534 1994 Postal survey on a randomized sample of 1000 
Swedish citizens selected from the general 
population from an address register
Thailand Tongsiri et al. [16] 1409 2007 Face-to-face interviews on a random national 
sample provided by the national statistical 
office
United Kingdom Kind et al. [17] 3395 1993 Face-to-face interviews on a random sample of 
5324 individuals selected from the general 
population (based on the Postcode Address 
file) from England, Scotland, and Wales
United States MEPS, Sullivan et al. [18] 38,678 2000–2002 Paper-and-pencil questionnaire among the 
Medical Expenditure Panel Survey partici-
pants, a nationally representative survey of 
the US civilian noninstitutionalized popula-
tion. The research pooled 2000, 2001, and 
2002 MEPS data on 23,839, 32,122, and 
37,418 individuals, using a stratified, multi-
stage, clustered sampling design
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A non-parametric measure (Spearman rank correlation) 
was used to assess the association between self-reported 
health using EQ-5D and the above-mentioned indicators of 
living standards and health system performance. We expected 
that poorer populations will show more reported health prob-
lems than richer populations, and countries with a shorter life 
expectancy will also display more reported health problems. 
Generally, the positive association of good health with higher 
health expenditures probably rests on a common explanatory 
factor, i.e., wealth on the country level. As additional explora-
tory analysis, we performed linear regression analyses on mac-
roeconomic indicators and mean VAS rating.
The inclusion of both the European VAS value set as well 
as country-specific VAS value sets allowed for exploring the 
impact of the preferences of a specific country, using the 
European VAS value set as a reference. The inclusion of the 
country-specific TTO value sets also allowed for exploring 
the effect of valuation method (VAS versus TTO). All data 
analyses were performed using SPSS version 19 and Stata 
version 12 statistical software packages.
Results
EQ‑5D population norms
Results for reported problems along the five dimensions 
by gender for each country are presented in Table 3. As 
hypothesized, reported health problems were generally 
higher for females, with the exception of Slovenia. Problems 
with pain/discomfort were generally the most prevalent in 
each country, while problems with self-care were the least 
prevalent across countries. Thailand and Slovenia appeared 
to have generally high reported problems in all dimensions 
compared to other countries, while China and Korea showed 
the lowest reported problems. The pattern of reported prob-
lems across the five dimensions was rather similar across 
countries, although the absolute number of reported prob-
lems varies.
Table 4 shows results for self-rated EQ VAS scores for 
each country by age and gender and for the total popula-
tion. EQ VAS ratings decreased with increasing age and 
were generally lower for females in all countries, which 
confirmed our hypotheses. Country-specific differences can 
be observed in the overall level of health (mean EQ VAS 
ratings), and to a lesser extent in the level of health decrease 
(age-slope). Korea displayed a very small age slope. The 
age slope was considerably higher in Southeastern Europe 
compared to Northwestern Europe. Gender differences 
were generally more pronounced with increasing age, and 
stronger for some countries while almost absent in others 
(New Zealand, Slovenia, and Thailand). For illustrative pur-
poses, Fig. 1 shows the detailed age and gender pattern for 
the pooled dataset. 
EQ-5D index norm values based on the European value 
set generally decreased with age, with values ranging from 
Table 2  Country-specific macroeconomic indicators
*Data availability for last year varies in some countries
GDP per capita 
($) 2010
Unemployment rate 
(%) 2010*
Health expenditure (% of 
GDP) 2010*
Health expenditure per 
capita ($) 2010*
Physicians per 1000 
people 2004-2009
Argentina 9124 8.6 8.1 742 3.2
Belgium 43,006 8.3 10.7 4618 3.0
China 4433 4.3 5.1 221 1.4
Denmark 56,486 7.4 11.4 6422 3.4
France 39,170 9.3 11.9 4691 3.5
Germany 40,164 7.1 11.6 4668 3.5
Greece 25,832 12.5 10.2 2729 6.0
Hungary 12,863 11.2 7.3 942 3.1
Italy 33,787 8.4 9.5 3248 4.2
Korea 20,540 3.7 6.9 1439 2.0
Netherlands 46,623 4.5 11.9 5593 3.9
New Zealand 32,407 6.5 10.1 3279 2.4
Slovenia 22,898 7.2 9.4 2154 2.5
Spain 29,956 20.1 9.5 2883 3.7
Sweden 49,360 8.4 9.6 4710 3.8
Thailand 4614 1.2 3.9 179 0.3
United Kingdom 36,256 7.8 9.6 3503 2.7
United States 46,612 9.6 17.9 8362 2.4
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0.814–0.990 in the youngest group, to 0.621–0.840 in the 
75 + group. Corresponding EQ-5D index values in coun-
tries where TTO-based value sets were available ranged 
from 0.924 to 0.984 in the youngest group to 0.703–0.839 
in the 75 + group. Finally, EQ-5D index values in countries 
where VAS-based value sets were available ranged from 
0.869 to 0.962 in the youngest group to 0.498–0.817 in the 
75 + group. Population norms based on the European VAS 
value set were generally higher than or similar to country-
specific VAS value sets (except for Germany), while popula-
tion norms based on country-specific TTO value sets tended 
to be higher compared to the same countries using country-
specific VAS-based value sets (see Tables 5, 6). 
Cross‑country comparison
Table 7 shows the impact of age standardization of popu-
lation norms, which were usually within a few percent-
age points of difference. Mean EQ VAS score varied from 
70.4 to 83.3 in the total population. The largest differ-
ences between any two countries in reporting problems 
were 28.6, 12.7, 31.9, 53.7, and 43.8% in absolute terms 
along the five dimensions, respectively. Hungary reported 
the lowest EQ VAS ratings (70.4), followed by Korea 
(71.3), while Denmark (83.3) and the United Kingdom 
(82.8) reported the highest EQ VAS ratings. The highest 
proportion of problems on the five EQ-5D dimensions was 
reported by Slovenia and Thailand. It needs to be noted 
that while Hungary and Korea reported a lower mean EQ 
VAS than Slovenia and Thailand, generally more prob-
lems were reported in Slovenia and Thailand across the 
five dimensions. At the other end of the spectrum, China 
reported the lowest proportion of problems but reported 
average EQ VAS ratings, while Denmark and the UK 
reported the highest EQ VAS ratings and average propor-
tions of problems. These results indicate that countries 
also differed in the overall level of health resulting from 
the more general EQ VAS question relative to the more 
specific questions on the EQ-5D dimensions.
Table 8 shows the association on the country level of 
the macroeconomic indicators and the EQ VAS rating and 
reported health problems. As hypothesized, the prior living 
standards (GDP per capita) and health expenditure per capita 
in the countries studied were correlated with the mean EQ 
VAS scores (0.58 and 0.55, respectively). Unemployment 
significantly correlated in people over the age of 45 only. 
The number of physicians did not correlate with better EQ 
VAS data (0.03). Contrary to our expectations, life expec-
tancy did not result in any significant association.
The positive relationship between living standards and 
self-reported EQ VAS was further examined and is graphi-
cally presented in Fig. 2. As shown, EQ VAS correlated 
well with a country’s GDP, although China and Thailand 
were outliers with an exceptionally low GDP (combined 
Table 3  Reported problems by 
five dimensions (proportions 
(%) of respondents scoring any 
problem, not standardized)
Mobility Self-care Usual activities Pain/discomfort Anxiety/depres-
sion
Females Males Females Males Females Males Females Males Females Males
Argentina 13 9 3 2 10 6 36 25 26 19
Belgium 15 10 5 3 15 10 31 26 8 5
China 6 4 3 3 6 4 13 8 10 7
Denmark 12 10 3 2 20 15 40 33 19 12
Finland 29 24 12 9 24 18 52 43 15 12
France 16 11 4 4 11 9 38 33 16 13
Germany 17 15 3 2 11 9 30 25 5 4
Greece 14 13 9 3 12 9 20 14 12 10
Hungary 23 16 7 6 17 12 45 32 42 27
Italy 12 9 5 2 12 7 31 22 11 6
Korea 9 3 1 0 6 2 27 16 23 12
Netherlands 13 9 4 2 16 10 38 30 4 2
New Zealand 20 20 4 5 22 21 41 40 24 18
Slovenia 28 32 14 14 33 33 48 47 38 34
Spain 16 11 6 3 14 8 27 17 10 5
Sweden 10 7 2 1 8 8 42 40 31 21
Thailand 28 24 8 9 22 23 68 62 51 43
UK 19 18 4 4 16 17 34 32 23 18
UK—England 21 18 6 5 18 15 37 33 22 16
United States 22 17 5 5 23 17 49 41 32 23
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with relatively high EQ VAS scores). The European value 
set showed a more moderate correlation with GDP with only 
China as outlier and a smaller slope.
Linear regression analyses showed that GDP level 
explained 29% of EQ VAS at the country level (p = 0.02), 
but explained 67% of the EQ VAS when excluding ‘outli-
ers’ China and Thailand. Health expenditure per capita was 
the only other statistically significant explanatory factor 
that explained 26% of the country mean VAS (p = 0.03). 
Another set of regression analyses, which used macro data 
from the year of EQ-5D data collection in each country on 
gross national income expressed in purchasing power parity 
in 2010 values, did not yield statistically significant results. 
However, health care expenditure remained a statistically 
significant factor (p = 0.03), explaining 27% of variation in 
the country mean VAS scores.
Discussion
The current study generated population norms for self-rated 
EQ VAS and EQ-5D index values, and for self-reported 
problems on each of the five dimensions of the EQ-5D 
descriptive system for 20 countries, all classified by age. 
These EQ-5D norms are highly relevant for future research 
initiatives, as they can be used to compare EQ-5D data from 
patients to the average person in the general population of 
a certain country in a similar age (or gender) group, which 
also helps to identity the burden of the disease of patients 
or patient groups. This multi-country analysis is unique in 
terms of reporting EQ-5D data based on a standard meth-
odology and allowing for comparisons across countries and 
explaining differences using macroeconomic indicators.
Our hypothesis on age and gender was confirmed by 
results for both the EQ VAS and reported problems on the 
five dimensions (where the age effect was visible through 
50
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18212427303336394245485154576063666972757881848790
EQ
 V
AS
Age
Males
Females
Fig. 1  Self-rated mean EQ VAS by age and gender (pooled dataset*). 
* Including data for all countries except Argentina and China, which 
were not added to the central data archive
Table 5  EQ-5D index value 
population norms by age group 
and total population (European 
VAS value set)
N/A: not available
18–24 25–34 35–44 45–54 55–64 65–74 75 + Total
Argentina 0.907 0.889 0.869 0.849 0.829 0.796 0.724 0.856
Belgium 0.953 0.921 0.920 0.889 0.881 0.848 0.761 0.891
China 0.990 0.980 0.970 0.960 0.930 0.900 0.840 0.951
Denmark 0.914 0.914 0.881 0.861 0.845 0.818 0.753 0.866
Finland N/A 0.919 0.891 0.853 0.805 0.762 0.573 0.815
France 0.924 0.921 0.883 0.893 0.836 0.804 0.756 0.872
Germany 0.950 0.949 0.943 0.908 0.881 0.838 0.771 0.902
Greece 0.979 0.972 0.957 0.916 0.817 0.793 0.739 0.913
Hungary 0.934 0.911 0.873 0.802 0.755 0.716 0.639 0.823
Italy 0.969 0.956 0.943 0.910 0.877 0.823 0.724 0.899
Korea 0.957 0.958 0.949 0.915 0.828 0.787 N/A 0.915
Netherlands 0.938 0.910 0.922 0.874 0.869 0.863 0.798 0.892
New Zealand 0.913 0.906 0.893 0.858 0.817 0.800 0.712 0.848
Slovenia 0.879 0.859 0.831 0.772 0.697 0.663 0.621 0.788
Spain 0.968 0.963 0.939 0.911 0.884 0.870 0.773 0.915
Sweden 0.888 0.893 0.868 0.835 0.813 0.836 0.701 0.851
Thailand 0.814 0.785 0.771 0.717 0.694 0.670 0.657 0.742
UK 0.934 0.922 0.905 0.849 0.804 0.785 0.734 0.856
UK—England 0.922 0.915 0.891 0.857 0.819 0.785 0.720 0.857
US 0.899 0.883 0.853 0.809 0.776 0.756 0.677 0.825
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the index values, providing a summary score for the five 
dimensions). Cross-country differences occurred in EQ-5D 
outcomes in terms of the overall level of health but also in 
terms of the age slope, which was considerably higher in 
Southeastern Europe compared to Northwestern Europe. The 
overall patterns in each country regarding reported problems 
Table 6  EQ-5D index value 
population norms by age group 
and total population (country-
specific TTO and VAS value 
sets)
N/A: not available
18–24 25–34 35–44 45–54 55–64 65–74 75 + Total
TTO value sets
 Argentina 0.951 0.936 0.919 0.898 0.874 0.835 0.756 0.902
 Denmark 0.928 0.927 0.901 0.882 0.870 0.847 0.794 0.887
 France 0.948 0.946 0.913 0.922 0.853 0.810 0.735 0.892
 Germany 0.972 0.973 0.966 0.945 0.922 0.891 0.839 0.938
 Italy 0.984 0.978 0.973 0.955 0.936 0.904 0.839 0.947
 Korea 0.981 0.982 0.976 0.960 0.909 0.888 N/A 0.958
 Netherlands 0.950 0.927 0.935 0.890 0.890 0.886 0.830 0.910
 Spain 0.982 0.975 0.949 0.923 0.901 0.891 0.781 0.929
 UK 0.940 0.927 0.911 0.847 0.799 0.779 0.726 0.856
 UK—England 0.929 0.919 0.893 0.855 0.810 0.773 0.703 0.855
 US 0.924 0.912 0.889 0.855 0.830 0.817 0.755 0.867
VAS value sets
 Argentina 0.928 0.911 0.888 0.867 0.837 0.793 0.712 0.871
 Belgium 0.948 0.915 0.912 0.881 0.871 0.836 0.748 0.883
 Denmark 0.885 0.884 0.845 0.822 0.799 0.766 0.691 0.826
 Finland N/A 0.909 0.878 0.835 0.781 0.738 0.583 0.800
 Germany 0.962 0.966 0.962 0.937 0.915 0.882 0.817 0.930
 New Zealand 0.890 0.883 0.869 0.827 0.782 0.763 0.672 0.818
 Slovenia 0.869 0.841 0.794 0.712 0.619 0.554 0.498 0.738
 Spain 0.969 0.963 0.939 0.912 0.883 0.866 0.761 0.914
 UK 0.931 0.920 0.902 0.846 0.799 0.778 0.726 0.852
 UK—England 0.922 0.914 0.888 0.854 0.814 0.775 0.706 0.853
Table 7  Self-reported EQ-5D 
results after age standardization 
(mean EQ VAS and proportions 
(%) of respondents scoring any 
problem)
EQ-VAS Mobility Self-care Usual activity Pain/discomfort Anxiety/
depression
Argentina 73.9 13.3 3.7 9.8 33.9 23.8
Belgium 77.4 13.9 4.8 12.9 29.4 6.1
China 79.9 6.1 3.4 6.1 11.5 9.2
Denmark 83.3 11.5 2.8 18.6 37.0 16.2
France 76.3 14.4 4.6 10.7 35.8 14.5
Germany 77.2 17.2 3.1 10.5 27.8 4.5
Greece 76.5 17.2 8.3 13.7 20.4 11.2
Hungary 70.4 20.9 7.2 15.8 40.4 36.2
Italy 76.9 12.3 4.4 11.1 27.7 9.2
Korea 71.3 6.5 1.0 4.6 29.6 22.9
Netherlands 81.4 11.8 3.5 12.5 32.6 3.2
New Zealand 80.8 19.2 4.3 20.8 39.3 21.2
Slovenia 74.5 34.7 16.7 36.5 51.0 38.0
Spain 74.3 12.7 4.0 11.0 21.3 7.3
Sweden 82.5 11.3 2.5 9.6 42.5 26.4
Thailand 78.9 29.8 9.2 25.9 65.2 47.0
United Kingdom 82.8 18.2 4.3 16.2 33.1 20.9
US 79.3 19.3 3.7 18.3 48.0 22.4
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were spectacularly similar in terms of pain/discomfort being 
the most prevalent and self-care being the least prevalent 
problem. However, the actual rates of reporting problems 
differed widely across countries after accounting for demo-
graphic differences, and no consistent trend was observed 
on how countries score in terms of EQ VAS relative to mor-
bidity reported along the five dimensions, which seems to 
indicate that the EQ VAS is measuring a different (or at least 
wider) health concept than the five dimensions of EQ-5D, or 
that countries differ in responses to the various dimensions. 
Table 8  Spearman rank correlations between macroeconomic indicators and self-reported health  (mean self-rated EQ VAS and proportion of 
any reported problem)
*p < 0.05
EQ-VAS
Age group GDP per capita Unemployment Health expenditure 
(% of GDP)
Health expendi-
ture per capita
Physicians per 
1000 people
Life expectancy
 18–24 0.38 − 0.12 0.29 0.40 0.09 − 0.15
 25–34 0.55* − 0.06 0.44 0.53* 0.32 0.02
 35–44 0.50* − 0.26 0.35 0.47 0.18 0.09
 45–54 0.49* − 0.50* 0.29 0.48* − 0.13 0.13
 55–64 0.45 − 0.50* 0.26 0.45 − 0.25 0.13
 65–74 0.47 − 0.48* 0.20 0.44 − 0.21 0.21
 75 + 0.42 − 0.51* 0.17 0.37 − 0.24 0.02
 Total 0.58* − 0.35 0.39 0.55* − 0.03 0.00
EQ-5D dimension
GDP per capita Unemployment 
rate
Health expenditure 
(% of GDP)
Health expendi-
ture per capita
Physicians per 
1000 people
Life expectancy
 Mobility − 0.19 0.14 0.04 − 0.13 − 0.27 − 0.34
 Self-care − 0.35 0.26 − 0.14 − 0.35 − 0.05 − 0.19
 Usual activities 0.08 − 0.03 0.13 0.09 − 0.24 − 0.27
 Pain/discomfort 0.10 − 0.11 − 0.01 0.12 − 0.38 − 0.31
 Anxiety/depression − 0.38 − 0.04 − 0.51* − 0.38 − 0.46 − 0.41
Argenna
Belgium
China
Denmark
France
Germany
Greece
Hungary
Italy
Korea
Netherlands
New Zealand
Slovenia
Spain
Sweden
Thailand
UK
US
68
70
72
74
76
78
80
82
84
$0 $10,000 $20,000 $30,000 $40,000 $50,000 $60,000
EQ
 V
AS
GDP
Argenna
Belgium
China
Denmark
France
Germany
Greece
Hungary
Italy
Korea
Netherlands
New Zealand
Slovenia
Spain
Sweden
Thailand
UK
US
70
75
80
85
90
95
100
$0 $10,000 $20,000 $30,000 $40,000 $50,000 $60,000
EQ
 in
de
x 
(E
ur
op
ea
n 
va
lu
e 
se
t)
GDP
Fig. 2  Self-rated EQ VAS and index values (European value set) according to GDP* per capita in 18 countries (mean values after age standardi-
zation). *GDP is the total value of all goods and services produced by an economy in 1 year
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An obvious implication of these findings for multi-country 
studies with the EQ-5D is the need to factor in the country 
of origin of patients when analyzing and interpreting results.
In addition, when examining population norms for EQ-5D 
index values, results highlighted the importance of also tak-
ing into account the value set used to calculate the EQ-5D 
index when interpreting results or making comparisons 
across studies. Country-specific value sets are generally rec-
ommended for use in the corresponding country, while for 
comparative purposes, the European value set seems to be 
the most optimal choice. Country-specific value sets showed 
differences between valuation methods, which is consistent 
with previous evidence indicating that TTO methodology 
leads to higher values than VAS-based techniques [29].
The fact itself that self-reported health differs across 
countries is not unexpected. Previous studies, such as those 
based on categorical assessment of self-assessed health [30], 
or those based on generic quality of life questionnaires [31], 
found results that self-reported health differed across coun-
tries. These cross-country differences in the general level of 
health (EQ VAS) were at least partially explained by looking 
at macro data on the living standards and health system char-
acteristics of each country. The analysis highlighted that it 
is the prior living standards of a country that mostly explain 
cross-country differences in self-reported health. Indeed, the 
result that GDP level explained 67% of EQ VAS at the coun-
try level when excluding two ‘outlier’ countries underlined 
the high importance of viewing self-reported health within 
a broader macroeconomic context. At the same time, health 
expenditure per capita was also quantified to be an impor-
tant factor, one that policy-makers at a national level have 
more control over than determining annual GDP. In addition, 
while GDP showed a stronger correlation with VAS than 
health expenditure, a dollar unit of health expenditure had 
eight times the impact of a dollar unit of GDP on the coun-
try mean VAS scores (with coefficients of 0.0001 for GDP 
and 0.0008 for health expenditure). However, expenditure 
might be confused with GDP, since a high GDP might lead 
to higher health care expenditures, which in turn might influ-
ence the number and quality of interventions per capita, and 
consequently lead to better health in a population.
The most important limitation of this analysis relates to 
differences in samples across countries. While all samples 
were representative samples of the general population of 
each country, differences exist across study methodologies, 
such as sample size, administration method, purpose of data 
collection, and time of the data collection. While adjust-
ments were made for sample structure, some of these fac-
tors may have influenced the comparability of the results. In 
particular, some surveys in the dataset archive were older, 
and limited evidence suggests that population norms may 
or may not change over time, depending on the country [3]. 
Non-response may have introduced a potential bias towards 
underestimation of self-reported health problems. Some 
countries applied a sampling design, whereas other coun-
tries did not, which might lead to a more accurate reflec-
tion of representativeness for the former. Although mode 
of administration might contribute to observed differences, 
a recent study showed equivalence between various modes 
of administration using the EQ-5D [32]. Further variability 
between countries might be caused by translations of the 
different versions of the EQ-5D. Another limitation is the 
use of the European population structure for age standardiza-
tion, which might not be fully justified for the non-European 
countries, especially for China, where the population struc-
ture is quite different. Finally, influences due to reporting 
behavior heterogeneity, such as education, might also impact 
variability between self-reported health problems [33].
While results from these analyses can be used to compare 
profiles for patients with specific conditions or to assess the 
burden of disease in question, understanding inequalities in 
self-assessed health among the population is also important, 
but fell beyond the aims of this paper. However, more in-
depth analyses on contributors to levels of population health 
could be important.
Finally, this manuscript focused on existing data from 
the three-level version of the EQ-5D instrument; however, 
a more refined version of the EQ-5D (EQ-5D-5L), which 
extends the three response levels in each dimension to 
five levels, has been introduced [34]. The extra levels are 
expected to lead to a much more accurate reflection of popu-
lation health, especially in relation to mild health problems. 
Further important research in the field would be the report-
ing of population norms using the EQ-5D-5L version of the 
questionnaire.
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